Latest Neuroscientific Biopharmaceuticals (ASX:NSB) News
Page 1
Page 1 of 3
Healthcare Wrap - Week 44 (26 Oct -> 30 Oct) 2026
31 Oct 2026
NSB clears key FDA hurdle as StemSmart Phase 2 trial targets year-end start
27 Oct 2026
Market Wrap - Week 42 (12 Oct -> 16 Oct) 2026
17 Oct 2026
Healthcare Wrap - Week 42 (12 Oct -> 16 Oct) 2026
17 Oct 2026
FDA backs NSB’s StemSmart Phase 2 trial design for refractory Crohn’s disease
13 Oct 2026
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Healthcare Wrap - Week 33 (10 Aug -> 14 Aug) 2026
15 Aug 2026
NSB Secures FDA Pre-IND Meeting for StemSmart Phase 2 Trial in Refractory Crohn’s
13 Aug 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
NeuroScientific Reports 80% Clinical Response in Crohn’s Disease Patients with StemSmart
28 July 2026
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026